Dr. Matthias Eikermann, MD, PHD
Claim this profileMontefiore Medical Center/Albert Einstein college of Medicine
Studies Delirium
Studies Emergence Delirium
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Matthias Eikermann, MD, PHD is currently running
Suvorexant
for Sleep Disorders in ICU Patients
Investigators will evaluate the efficacy of postoperative oral suvorexant treatment on nighttime wakefulness after persistent sleep onset (WASO) among adult cardiac surgical patients recovering in the cardiac intensive care unit (ICU). The study include patients ≥ 60 years old undergoing coronary artery bypass graft surgery (CABG), with or without valve surgery (aortic or mitral). Patients will receive either oral suvorexant or placebo for 7 nights starting the night after extubation. The primary hypothesis is that suvorexant compared with placebo decreases WASO, as measured by a specialized electroencephalogram (EEG), the SedLine monitor, during the first night in the cardiac ICU. Investigators will also assess total sleep time (TST), time to sleep onset (TSO), and postoperative delirium and delirium-free days.
Recruiting2 awards Phase 42 criteria
IV Acetaminophen
for Delirium After Cardiac Surgery
Our objective is to find an effective prophylactic intervention by evaluating IV acetaminophen's impact in reducing the frequency of postoperative delirium, one of the most common and detrimental complications of cardiac surgery in older adults.
Recruiting1 award Phase 32 criteria
More about Matthias Eikermann, MD, PHD
Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Matthias Eikermann, MD, PHD has experience with
- Placebo
- Placebo Oral Tablet
- Suvorexant
- IV Acetaminophen
- Dexmedetomidine
Breakdown of trials Matthias Eikermann, MD, PHD has run
Delirium
Emergence Delirium
Sleep Deprivation
Sleep Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthias Eikermann, MD, PHD specialize in?
Matthias Eikermann, MD, PHD focuses on Delirium and Emergence Delirium. In particular, much of their work with Delirium has involved treating patients, or patients who are undergoing treatment.
Is Matthias Eikermann, MD, PHD currently recruiting for clinical trials?
Yes, Matthias Eikermann, MD, PHD is currently recruiting for 3 clinical trials in Bronx New York. If you're interested in participating, you should apply.
Are there any treatments that Matthias Eikermann, MD, PHD has studied deeply?
Yes, Matthias Eikermann, MD, PHD has studied treatments such as Placebo, Placebo oral tablet, Suvorexant.
What is the best way to schedule an appointment with Matthias Eikermann, MD, PHD?
Apply for one of the trials that Matthias Eikermann, MD, PHD is conducting.
What is the office address of Matthias Eikermann, MD, PHD?
The office of Matthias Eikermann, MD, PHD is located at: Montefiore Medical Center/Albert Einstein college of Medicine, Bronx, New York 10467 United States. This is the address for their practice at the Montefiore Medical Center/Albert Einstein college of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.